S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

OraSure Technologies Stock Forecast, Price & News

-0.09 (-0.84 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $10.60
50-Day Range
MA: $13.34
52-Week Range
Now: $10.60
Volume1.27 million shs
Average Volume1.00 million shs
Market Capitalization$760.37 million
P/E RatioN/A
Dividend YieldN/A
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, and OraSure QuickFlu Rapid Flu A&B test; OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; tuberculosis products; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 2000 and is based in Bethlehem, Pennsylvania.
OraSure Technologies logo


OraSure Technologies's Earnings: A Preview
February 26, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:OSUR
Year FoundedN/A



Sales & Book Value

Annual Sales$154.60 million
Cash Flow$0.21 per share
Book Value$4.98 per share


Net Income$16.66 million


Market Cap$760.37 million
Next Earnings Date3/1/2021 (Confirmed)


Overall MarketRank

1.69 out of 5 stars

Medical Sector

251st out of 1,960 stocks

Surgical & Medical Instruments Industry

27th out of 167 stocks

Analyst Opinion: 3.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
-0.09 (-0.84 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OSUR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

Is OraSure Technologies a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OraSure Technologies stock.
View analyst ratings for OraSure Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than OraSure Technologies?

Wall Street analysts have given OraSure Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OraSure Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is OraSure Technologies' next earnings date?

OraSure Technologies is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for OraSure Technologies

How can I listen to OraSure Technologies' earnings call?

OraSure Technologies will be holding an earnings conference call on Monday, March 1st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) released its quarterly earnings results on Wednesday, November, 4th. The medical instruments supplier reported $0.01 earnings per share for the quarter, beating analysts' consensus estimates of ($0.06) by $0.07. The medical instruments supplier had revenue of $48.01 million for the quarter, compared to the consensus estimate of $39.20 million. OraSure Technologies had a negative net margin of 9.05% and a negative trailing twelve-month return on equity of 3.51%. The company's revenue for the quarter was up 33.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.21 EPS.
View OraSure Technologies' earnings history

How has OraSure Technologies' stock price been impacted by COVID-19?

OraSure Technologies' stock was trading at $5.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, OSUR stock has increased by 79.7% and is now trading at $10.60.
View which stocks have been most impacted by COVID-19

What price target have analysts set for OSUR?

6 analysts have issued 12-month target prices for OraSure Technologies' shares. Their forecasts range from $14.00 to $22.00. On average, they anticipate OraSure Technologies' stock price to reach $17.83 in the next year. This suggests a possible upside of 68.2% from the stock's current price.
View analysts' price targets for OraSure Technologies
or view top-rated stocks among Wall Street analysts.

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the following people:
  • Dr. Stephen S. Tang, Pres, CEO & Director (Age 60, Pay $871.83k)
  • Mr. Roberto E. Cuca, CFO & Principal Accounting Officer (Age 53, Pay $562.6k)
  • Mr. Jack E. Jerrett, Sr. VP, Chief Compliance Officer, Gen. Counsel & Sec. (Age 62, Pay $477.29k)
  • Ms. Kathleen Gallagher Weber, Exec. VP & Bus. Unit Leader of Molecular Solutions (Age 54, Pay $530.29k)
  • Ms. Jeanne Mell, VP of Corp. Communications
  • Ms. Lisa Nibauer, Exec. VP & Bus. Unit Leader of Infectious Disease
  • Ms. Michele Marie Miller, VP of Fin., Controller & Assistant Sec. (Age 47)

What is Stephen Tang's approval rating as OraSure Technologies' CEO?

2 employees have rated OraSure Technologies CEO Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among OraSure Technologies' employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of OraSure Technologies' key competitors?

What other stocks do shareholders of OraSure Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

Who are OraSure Technologies' major shareholders?

OraSure Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.38%), Dimensional Fund Advisors LP (4.11%), Kennedy Capital Management Inc. (2.36%), Primecap Management Co. CA (1.91%), Renaissance Technologies LLC (1.62%) and Northern Trust Corp (1.29%). Company insiders that own OraSure Technologies stock include Jack E Jerrett, Roberto Cuca and Stephen S Phd Tang.
View institutional ownership trends for OraSure Technologies

Which major investors are selling OraSure Technologies stock?

OSUR stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Kennedy Capital Management Inc., Dimensional Fund Advisors LP, Primecap Management Co. CA, JPMorgan Chase & Co., Fisher Asset Management LLC, Nuveen Asset Management LLC, and Barclays PLC.
View insider buying and selling activity for OraSure Technologies
or view top insider-selling stocks.

Which major investors are buying OraSure Technologies stock?

OSUR stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Nia Impact Advisors LLC, Robeco Institutional Asset Management B.V., Kornitzer Capital Management Inc. KS, First Trust Advisors LP, Tygh Capital Management Inc., Verition Fund Management LLC, and Russell Investments Group Ltd.. Company insiders that have bought OraSure Technologies stock in the last two years include Jack E Jerrett, Roberto Cuca, and Stephen S Phd Tang.
View insider buying and selling activity for OraSure Technologies
or or view top insider-buying stocks.

How do I buy shares of OraSure Technologies?

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $10.60.

How much money does OraSure Technologies make?

OraSure Technologies has a market capitalization of $760.37 million and generates $154.60 million in revenue each year. The medical instruments supplier earns $16.66 million in net income (profit) each year or $0.13 on an earnings per share basis.

How many employees does OraSure Technologies have?

OraSure Technologies employs 472 workers across the globe.

What is OraSure Technologies' official website?

The official website for OraSure Technologies is www.orasure.com.

Where are OraSure Technologies' headquarters?

OraSure Technologies is headquartered at 220 EAST FIRST STREET, BETHLEHEM PA, 18015.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at 610-882-1820 or via email at [email protected]

This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.